{"expires": 1766435180, "value": "{\"cagr_1y\": 8.5, \"cagr_2y\": 9.2, \"cagr_5y\": 10.1, \"cagr_10y\": 9.5, \"reasoning\": \"Based on the provided financial data and considering the sector and beta, a conservative estimate is made. The current and forward P/E ratios suggest a relatively stable valuation. The lack of ROE and ROIC data limits the analysis, but the gross and operating margins indicate a moderate level of profitability. Given the healthcare sector's historical performance and the company's beta, these CAGR estimates reflect a balanced outlook.\"}"}